CoChat

SLC6 Transporter Folding Diseases and Pharmacochaperoning

Freissmuth, Michael, Stockner, Thomas, Sucic, Sonja · 2017 · Handbook of experimental pharmacology

The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.

Abstract

The human genome encodes 19 genes of the solute carrier 6 (SLC6) family; non-synonymous changes in the coding sequence give rise to mutated transporters, which are misfolded and thus cause diseases in the affected individuals. Prominent examples include mutations in the transporters for dopamine (DAT, SLC6A3), for creatine (CT1, SLC6A8), and for glycine (GlyT2, SLC6A5), which result in infantile dystonia, mental retardation, and hyperekplexia, respectively. Thus, there is an obvious unmet medical need to identify compounds, which can remedy the folding deficit. The pharmacological correction of folding defects was originally explored in mutants of the serotonin transporter (SERT, SLC6A4), which were created to study the COPII-dependent export from the endoplasmic reticulum. This led to the serendipitous discovery of the pharmacochaperoning action of ibogaine. Ibogaine and its metabolite noribogaine also rescue several disease-relevant mutants of DAT. Because the pharmacology of DAT and SERT is exceptionally rich, it is not surprising that additional compounds have been identified, which rescue folding-deficient mutants. These compounds are not only of interest for restoring DAT function in the affected children. They are also likely to serve as useful tools to interrogate the folding trajectory of the transporter. This is likely to initiate a virtuous cycle: if the principles underlying folding of SLC6 transporters are understood, the design of pharmacochaperones ought to be facilitated.

Overview

Integrity signals

Registry

Crossref · 10.1007/164_2017_71

Cites

91 of 91 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 91 references

Research works printed but not linked: 1

  1. Levinthal C (1969) How to fold graciously. In: DeBrunner JTP, Munck E (eds) Mössbauer spectroscopy in biological systems. University of Illinois Press, Allerton House, Monticello, IL, pp 22–24

Cited by

See all 45

Metadata

Authors
Freissmuth, M., Stockner, T., & Sucic, S.
Affiliations
Medical University of Vienna (AT)
Corresponding author
Freissmuth, Michael
Venue
Handbook of experimental pharmacology
Published
2017
Volume
245
Pages
249-270
ISSN
  • 0171-2004 (ISSN-L)
  • 1865-0325
OpenAlex
W2765579156
Cited by
42
References
90
Citations by year
2026: 3 · 2025: 4 · 2024: 5 · 2023: 7 · 2022: 4 · 2021: 7 · 2020: 4 · 2019: 4 · 2018: 3 · 2017: 1
FWCI
4.08
Type
book chapter
Language
en
Open access
closed
Locations
  • Handbook of experimental pharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion Transport and Channel Regulation
Keywords
pharmacochaperone, protein folding defects, dopamine transporter, serotonin transporter, creatine transporter, glycine transporter, ibogaine, noribogaine, hyperekplexia, intellectual disability, endoplasmic reticulum
MeSH terms
Solute Carrier Proteins, Animals, Humans, Mutation, Protein Folding, Molecular Chaperones, Dopamine Plasma Membrane Transport Proteins, Serotonin Plasma Membrane Transport Proteins, Drug Discovery, Proteostasis Deficiencies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: SLC6 Transporter Folding Diseases and Pharmacochaperoning. https://app.cochat.ai/papers/10.1007/164_2017_71
The paper
Freissmuth, M., Stockner, T., & Sucic, S. (2017). SLC6 Transporter Folding Diseases and Pharmacochaperoning. Handbook of experimental pharmacology. https://doi.org/10.1007/164_2017_71

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.